Intuition x Novartis PCC 2025
How Novartis Successfully Trained Their 3rd Party Vendors Over the Course of two CIAs How did Novartis successfully train their 3rd parties over the course of their last two CIAs and hit 100% completion? In this fast-paced session at the Pharmaceutical Compliance Congress (PCC) 2025, Novartis’ Catherine Shimsky joins Intuition’s Richard